Skip to main content
OpenTrials
Completed

NCT Number: NCT04544553

Barriers to Eye Screening for People With Diabetes in India

Brief Summary: Diabetic retinopathy (DR) is a leading cause of visual impairment and has major public health implications globally and especially in countries such as India where the prevalence of diabetes is high. With timely screening and intervention, the disease progression to blindness can be prevented but several barriers exist to the provision of care. The long term aim is to identify the barriers to DR screening and to plan potential interventional strategies. From the qualitative study, the reasons such as lack of awareness or knowledge, distance to travel, lack of reminder system were identified as a reason for poor follow-up. This lead to the development of interventional strategies.

This was a randomized, investigator-masked clinical trial that was conducted in a tertiary eye care centre in South India. Consecutive patients with diabetes who were residents in Chennai and its vicinity of approximately 100 km radius and who were undergoing repeated intravitreal injections for DME were recruited into the trial. The aim of the study is to investigate the effect of SMS informational reminders among patients with Diabetic macular edema for the follow-up. They study consists of 2 groups, SMS reminder group receives the reminders 1 week and 2 days prior to the scheduled appointments with the concerned doctor on a particular date and time, whereas other group does not receive any reminders for the appointment schedule. After the follow-up, the patients will be screened for the attendance at the review visit.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rajiv Raman

Chennai, Tamil Nadu, 600006, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with > 40 years of age
  • Diagnosed as centre involving Diabetic macular edema (DME)
  • Patients who received intravitreal injections for DME
  • Ability to give informed consent

Exclusion criteria

  • Patients from outside the area of residence who stayed more than 100 km from the hospital
  • Patients with ocular co-morbidities other than DME

Treatment and study plan

SMS reminder

Other

The group receives reminder for the follow-up at 1 week and 2 days prior to their scheduled appointments.

No SMS reminder

Other

The group did not receives any SMS regarding scheduled appoinments.

Primary outcomes

  1. Attendance rates in patients with diabetic macular edema receiving short messaging services

    Time frame: 7 months

    To investigate the effect of SMS informational reminders on adherence with scheduled eye examinations among patients with center involving DME receiving intravitreal injections in a tertiary eye care institute in South India.

Sponsors and collaborators

Lead sponsor

Lions Club International Foundation

Other

Registry information

Official study title

To Understand the Barriers and Facilitators of Diabetic Retinopathy Screening & Follow-up: An Exploratory Study From India and Thailand

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Sep 10, 2020
Registry last updated
Sep 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.